Laura Brown
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Growth Retardation | 34 | 2025 | 564 | 7.960 |
Why?
| | Fetus | 38 | 2024 | 806 | 5.880 |
Why?
| | Placental Insufficiency | 17 | 2025 | 116 | 5.110 |
Why?
| | Amino Acids | 21 | 2023 | 497 | 5.070 |
Why?
| | Sheep | 54 | 2025 | 855 | 4.860 |
Why?
| | Fetal Development | 14 | 2025 | 296 | 3.660 |
Why?
| | Muscle, Skeletal | 18 | 2025 | 1707 | 3.370 |
Why?
| | Glucose | 26 | 2024 | 1019 | 3.320 |
Why?
| | Insulin | 32 | 2024 | 2406 | 2.520 |
Why?
| | Pregnancy | 61 | 2025 | 6727 | 2.160 |
Why?
| | Insulin-Like Growth Factor I | 6 | 2024 | 316 | 1.980 |
Why?
| | Leucine | 10 | 2022 | 111 | 1.780 |
Why?
| | Myoblasts | 3 | 2021 | 84 | 1.680 |
Why?
| | Liver | 14 | 2024 | 1940 | 1.520 |
Why?
| | Fetal Heart | 2 | 2024 | 55 | 1.420 |
Why?
| | Oxidation-Reduction | 9 | 2024 | 1059 | 1.220 |
Why?
| | Infant, Premature | 6 | 2023 | 566 | 1.220 |
Why?
| | Dietary Proteins | 3 | 2023 | 135 | 1.200 |
Why?
| | Muscle Development | 4 | 2025 | 111 | 1.190 |
Why?
| | Animals | 63 | 2025 | 36836 | 1.130 |
Why?
| | Enteral Nutrition | 2 | 2023 | 201 | 1.110 |
Why?
| | Hyperinsulinism | 6 | 2020 | 121 | 1.060 |
Why?
| | Infant Nutritional Physiological Phenomena | 5 | 2023 | 144 | 1.040 |
Why?
| | Citrate (si)-Synthase | 2 | 2024 | 60 | 0.960 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2021 | 216 | 0.940 |
Why?
| | Cell Proliferation | 4 | 2024 | 2476 | 0.930 |
Why?
| | Fetal Weight | 3 | 2022 | 56 | 0.930 |
Why?
| | Placenta | 9 | 2024 | 749 | 0.880 |
Why?
| | Hindlimb | 3 | 2021 | 128 | 0.860 |
Why?
| | Mitochondria, Heart | 1 | 2024 | 100 | 0.840 |
Why?
| | Female | 66 | 2025 | 72785 | 0.820 |
Why?
| | Muscle Proteins | 3 | 2022 | 228 | 0.810 |
Why?
| | Maternal-Fetal Exchange | 7 | 2024 | 165 | 0.810 |
Why?
| | Parenteral Nutrition | 1 | 2023 | 107 | 0.790 |
Why?
| | Infant Formula | 3 | 2014 | 75 | 0.790 |
Why?
| | Pancreas | 7 | 2024 | 329 | 0.780 |
Why?
| | Infant, Extremely Premature | 1 | 2023 | 66 | 0.770 |
Why?
| | Hypoxia | 5 | 2021 | 1112 | 0.760 |
Why?
| | Myoblasts, Skeletal | 1 | 2021 | 12 | 0.750 |
Why?
| | Gluconeogenesis | 7 | 2024 | 79 | 0.740 |
Why?
| | Infant, Newborn | 10 | 2023 | 6031 | 0.700 |
Why?
| | Gestational Age | 11 | 2023 | 902 | 0.700 |
Why?
| | Infusions, Intravenous | 6 | 2024 | 412 | 0.680 |
Why?
| | Lactic Acid | 8 | 2024 | 305 | 0.670 |
Why?
| | Hypoglycemia | 6 | 2015 | 442 | 0.620 |
Why?
| | Protein Biosynthesis | 3 | 2017 | 430 | 0.600 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2023 | 1462 | 0.570 |
Why?
| | Ibuprofen | 1 | 2018 | 84 | 0.560 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2018 | 51 | 0.560 |
Why?
| | Hypoglycemic Agents | 3 | 2024 | 1283 | 0.520 |
Why?
| | Islets of Langerhans | 6 | 2024 | 803 | 0.480 |
Why?
| | Sweetening Agents | 1 | 2015 | 54 | 0.480 |
Why?
| | Lower Extremity | 1 | 2019 | 423 | 0.480 |
Why?
| | Disease Models, Animal | 9 | 2024 | 4281 | 0.470 |
Why?
| | Mitochondria | 1 | 2021 | 946 | 0.470 |
Why?
| | Cell Division | 1 | 2017 | 796 | 0.460 |
Why?
| | Oxidative Stress | 1 | 2021 | 1314 | 0.460 |
Why?
| | Glucagon | 6 | 2024 | 109 | 0.450 |
Why?
| | Blood Glucose | 12 | 2024 | 2181 | 0.440 |
Why?
| | Endocrine System | 1 | 2014 | 20 | 0.440 |
Why?
| | Myocytes, Cardiac | 1 | 2018 | 523 | 0.430 |
Why?
| | Milk, Human | 2 | 2020 | 158 | 0.430 |
Why?
| | Fetal Hypoxia | 3 | 2021 | 54 | 0.420 |
Why?
| | Growth | 1 | 2013 | 60 | 0.420 |
Why?
| | Developmental Disabilities | 1 | 2015 | 262 | 0.400 |
Why?
| | Intelligence | 1 | 2013 | 123 | 0.400 |
Why?
| | Dietary Carbohydrates | 2 | 2014 | 155 | 0.390 |
Why?
| | Dietary Supplements | 3 | 2012 | 559 | 0.380 |
Why?
| | Oxidative Phosphorylation | 2 | 2024 | 193 | 0.380 |
Why?
| | Organ Size | 5 | 2021 | 477 | 0.370 |
Why?
| | Fetal Blood | 7 | 2024 | 327 | 0.370 |
Why?
| | Placental Circulation | 2 | 2021 | 71 | 0.350 |
Why?
| | Hepatocytes | 5 | 2024 | 220 | 0.340 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2014 | 605 | 0.330 |
Why?
| | Glucose Clamp Technique | 4 | 2020 | 195 | 0.330 |
Why?
| | Metformin | 2 | 2024 | 330 | 0.330 |
Why?
| | Weight Gain | 1 | 2013 | 519 | 0.320 |
Why?
| | Insulin-Secreting Cells | 4 | 2024 | 372 | 0.320 |
Why?
| | Mannose | 1 | 2009 | 24 | 0.320 |
Why?
| | Inositol | 1 | 2009 | 26 | 0.310 |
Why?
| | Body Weight | 1 | 2013 | 985 | 0.310 |
Why?
| | Sugar Alcohols | 1 | 2008 | 3 | 0.300 |
Why?
| | Carbohydrates | 1 | 2008 | 65 | 0.290 |
Why?
| | Energy Metabolism | 3 | 2021 | 919 | 0.280 |
Why?
| | Postprandial Period | 1 | 2008 | 107 | 0.280 |
Why?
| | Milk | 1 | 2008 | 124 | 0.280 |
Why?
| | Random Allocation | 5 | 2012 | 353 | 0.280 |
Why?
| | Drug Administration Schedule | 4 | 2021 | 785 | 0.270 |
Why?
| | Pyruvic Acid | 2 | 2024 | 53 | 0.260 |
Why?
| | Oxygen | 6 | 2023 | 930 | 0.260 |
Why?
| | Proteins | 1 | 2012 | 1009 | 0.250 |
Why?
| | Glucagon-Secreting Cells | 2 | 2024 | 24 | 0.250 |
Why?
| | Livestock | 1 | 2025 | 10 | 0.240 |
Why?
| | Lipid Metabolism | 3 | 2024 | 512 | 0.230 |
Why?
| | Up-Regulation | 4 | 2017 | 844 | 0.230 |
Why?
| | Heat-Shock Response | 1 | 2025 | 77 | 0.230 |
Why?
| | Infant, Small for Gestational Age | 2 | 2022 | 91 | 0.220 |
Why?
| | Heat Stress Disorders | 1 | 2025 | 75 | 0.220 |
Why?
| | Cell Respiration | 1 | 2024 | 102 | 0.220 |
Why?
| | Humans | 21 | 2025 | 136750 | 0.210 |
Why?
| | Oxygen Consumption | 2 | 2024 | 695 | 0.210 |
Why?
| | Adaptation, Physiological | 2 | 2021 | 549 | 0.200 |
Why?
| | Amines | 1 | 2023 | 40 | 0.200 |
Why?
| | Ultrasonography, Prenatal | 2 | 2022 | 284 | 0.200 |
Why?
| | Blotting, Western | 4 | 2019 | 1225 | 0.190 |
Why?
| | Cystathionine gamma-Lyase | 1 | 2020 | 13 | 0.180 |
Why?
| | Placentation | 1 | 2021 | 45 | 0.170 |
Why?
| | Dairy Products | 1 | 2021 | 36 | 0.170 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 44 | 0.170 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2012 | 15 | 0.170 |
Why?
| | Meat | 1 | 2021 | 94 | 0.160 |
Why?
| | Bromodeoxyuridine | 1 | 2019 | 80 | 0.160 |
Why?
| | Body Composition | 2 | 2022 | 678 | 0.160 |
Why?
| | Amino Acid Transport Systems | 1 | 2020 | 42 | 0.160 |
Why?
| | Insulin Resistance | 4 | 2019 | 1203 | 0.160 |
Why?
| | Pregnancy, Animal | 1 | 2019 | 52 | 0.160 |
Why?
| | Blood Gas Analysis | 2 | 2012 | 74 | 0.160 |
Why?
| | Adipose Tissue | 2 | 2021 | 630 | 0.160 |
Why?
| | Gynecology | 1 | 2021 | 168 | 0.150 |
Why?
| | Adenosine Triphosphatases | 1 | 2020 | 165 | 0.150 |
Why?
| | Amino Acids, Branched-Chain | 4 | 2021 | 36 | 0.150 |
Why?
| | Sodium | 1 | 2020 | 216 | 0.150 |
Why?
| | Alanine | 1 | 2019 | 151 | 0.150 |
Why?
| | Point-of-Care Systems | 1 | 2020 | 163 | 0.150 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2016 | 32 | 0.150 |
Why?
| | Glucose-6-Phosphatase | 3 | 2016 | 33 | 0.150 |
Why?
| | Indomethacin | 1 | 2018 | 81 | 0.150 |
Why?
| | Anemia | 2 | 2017 | 170 | 0.140 |
Why?
| | RNA, Messenger | 4 | 2016 | 2831 | 0.140 |
Why?
| | Protein Kinases | 2 | 2009 | 319 | 0.130 |
Why?
| | Male | 9 | 2021 | 67305 | 0.130 |
Why?
| | Temperature | 1 | 2019 | 674 | 0.130 |
Why?
| | Infusion Pumps | 2 | 2021 | 32 | 0.120 |
Why?
| | Kinetics | 2 | 2012 | 1664 | 0.120 |
Why?
| | Acetaminophen | 1 | 2018 | 266 | 0.120 |
Why?
| | Lactates | 1 | 2015 | 85 | 0.120 |
Why?
| | Infant | 4 | 2023 | 9395 | 0.120 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2024 | 2518 | 0.120 |
Why?
| | Metabolomics | 1 | 2021 | 678 | 0.120 |
Why?
| | Breast Feeding | 2 | 2009 | 439 | 0.110 |
Why?
| | Endocrine System Diseases | 1 | 2014 | 35 | 0.110 |
Why?
| | Gene Expression Regulation | 4 | 2020 | 2605 | 0.110 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1089 | 0.110 |
Why?
| | Hydrops Fetalis | 1 | 2014 | 13 | 0.110 |
Why?
| | Pregnancy Complications | 1 | 2019 | 525 | 0.110 |
Why?
| | Nutritional Requirements | 1 | 2014 | 78 | 0.110 |
Why?
| | Hemangioma | 1 | 2014 | 48 | 0.110 |
Why?
| | Time Factors | 4 | 2012 | 6808 | 0.100 |
Why?
| | Diet | 1 | 2021 | 1274 | 0.100 |
Why?
| | Arginine | 2 | 2012 | 271 | 0.100 |
Why?
| | Algorithms | 3 | 2014 | 1688 | 0.100 |
Why?
| | Food | 1 | 2014 | 160 | 0.100 |
Why?
| | Carbon Dioxide | 2 | 2012 | 267 | 0.100 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2014 | 382 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2051 | 0.100 |
Why?
| | Acid-Base Equilibrium | 1 | 2012 | 28 | 0.100 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2014 | 176 | 0.100 |
Why?
| | Heart | 1 | 2016 | 653 | 0.090 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 121 | 0.090 |
Why?
| | Signal Transduction | 5 | 2020 | 5077 | 0.090 |
Why?
| | Sheep, Domestic | 3 | 2019 | 34 | 0.090 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2023 | 197 | 0.090 |
Why?
| | Carbon Isotopes | 1 | 2012 | 144 | 0.090 |
Why?
| | Malnutrition | 1 | 2012 | 82 | 0.090 |
Why?
| | Proteolysis | 1 | 2012 | 177 | 0.090 |
Why?
| | Tissue Distribution | 1 | 2012 | 330 | 0.090 |
Why?
| | Hormones | 1 | 2012 | 142 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 346 | 0.090 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2014 | 252 | 0.090 |
Why?
| | Apoptosis | 1 | 2019 | 2552 | 0.090 |
Why?
| | Taurine | 1 | 2011 | 46 | 0.080 |
Why?
| | Prospective Studies | 1 | 2022 | 7572 | 0.080 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2008 | 21 | 0.080 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 27 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2009 | 412 | 0.080 |
Why?
| | Somatostatin | 1 | 2008 | 61 | 0.070 |
Why?
| | Glycine | 2 | 2023 | 175 | 0.070 |
Why?
| | Galactose | 1 | 2008 | 33 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 152 | 0.070 |
Why?
| | Hydrocortisone | 3 | 2016 | 322 | 0.070 |
Why?
| | Acidosis | 1 | 2009 | 101 | 0.070 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 145 | 0.070 |
Why?
| | Lysine | 1 | 2009 | 294 | 0.060 |
Why?
| | Down-Regulation | 3 | 2017 | 656 | 0.060 |
Why?
| | Fetal Diseases | 2 | 2021 | 173 | 0.060 |
Why?
| | Embryo, Mammalian | 2 | 2019 | 232 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 103 | 0.050 |
Why?
| | Serine | 1 | 2023 | 141 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2019 | 975 | 0.050 |
Why?
| | Mammals | 1 | 2023 | 283 | 0.050 |
Why?
| | Amino Acids, Essential | 1 | 2021 | 13 | 0.040 |
Why?
| | Isoleucine | 1 | 2021 | 14 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2019 | 858 | 0.040 |
Why?
| | Fetal Macrosomia | 1 | 2021 | 62 | 0.040 |
Why?
| | Phenylalanine | 1 | 2021 | 68 | 0.040 |
Why?
| | Valine | 1 | 2021 | 82 | 0.040 |
Why?
| | Pancreatic Diseases | 1 | 2021 | 72 | 0.040 |
Why?
| | Carnitine | 1 | 2021 | 84 | 0.040 |
Why?
| | Mitochondria, Liver | 1 | 2020 | 73 | 0.040 |
Why?
| | Uterine Artery | 1 | 2020 | 79 | 0.040 |
Why?
| | Drug Synergism | 1 | 2020 | 383 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 319 | 0.040 |
Why?
| | Transcription Factors | 1 | 2007 | 1718 | 0.040 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 20 | 0.040 |
Why?
| | Glutathione | 1 | 2020 | 356 | 0.040 |
Why?
| | Birth Weight | 1 | 2021 | 514 | 0.040 |
Why?
| | Estrogens | 1 | 2020 | 368 | 0.030 |
Why?
| | Chronic Disease | 2 | 2017 | 1786 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 619 | 0.030 |
Why?
| | Diabetes, Gestational | 1 | 2021 | 316 | 0.030 |
Why?
| | Glycogen | 1 | 2016 | 55 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2016 | 85 | 0.030 |
Why?
| | Carbon Radioisotopes | 1 | 2014 | 34 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 384 | 0.030 |
Why?
| | Biological Transport | 1 | 2014 | 416 | 0.030 |
Why?
| | Blood Transfusion | 1 | 2016 | 324 | 0.030 |
Why?
| | Animals, Inbred Strains | 1 | 2012 | 7 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2014 | 302 | 0.030 |
Why?
| | Cell Size | 1 | 2012 | 91 | 0.020 |
Why?
| | Glutamic Acid | 1 | 2014 | 246 | 0.020 |
Why?
| | Electrolytes | 1 | 2012 | 58 | 0.020 |
Why?
| | Transcriptome | 1 | 2019 | 969 | 0.020 |
Why?
| | Solutions | 1 | 2012 | 167 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 162 | 0.020 |
Why?
| | Prenatal Diagnosis | 1 | 2014 | 200 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1772 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 190 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2021 | 5105 | 0.020 |
Why?
| | Energy Intake | 1 | 2014 | 484 | 0.020 |
Why?
| | Myocardium | 1 | 2016 | 1001 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 699 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2012 | 437 | 0.020 |
Why?
| | Adenylate Kinase | 1 | 2009 | 26 | 0.020 |
Why?
| | Infusions, Parenteral | 1 | 2009 | 40 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 44 | 0.020 |
Why?
| | Remission Induction | 1 | 2009 | 288 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2007 | 17 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 24 | 0.020 |
Why?
| | Fever | 1 | 2009 | 306 | 0.020 |
Why?
| | Receptor, Insulin | 1 | 2007 | 105 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4145 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 560 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2007 | 534 | 0.020 |
Why?
| | Mice | 1 | 2020 | 17758 | 0.010 |
Why?
| | Phosphorylation | 1 | 2007 | 1758 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1773 | 0.010 |
Why?
| | Obesity | 1 | 2011 | 2982 | 0.010 |
Why?
| | Adolescent | 1 | 2014 | 21380 | 0.010 |
Why?
| | Adult | 1 | 2011 | 37626 | 0.000 |
Why?
|
|
Brown's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|